Annual CFI
-$10.00 K
+$82.00 K+89.13%
December 31, 2023
Summary
- As of February 7, 2025, RSLS annual cash flow from investing activities is -$10.00 thousand, with the most recent change of +$82.00 thousand (+89.13%) on December 31, 2023.
- During the last 3 years, RSLS annual CFI has risen by +$2.38 million (+99.58%).
- RSLS annual CFI is now -100.12% below its all-time high of $8.25 million, reached on December 31, 2007.
Performance
RSLS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, RSLS quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, RSLS quarterly CFI has stayed the same.
- RSLS quarterly CFI is now -100.00% below its all-time high of $5.13 million, reached on June 30, 2021.
Performance
RSLS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, RSLS TTM cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, RSLS TTM CFI has increased by +$89.00 thousand (+100.00%).
- RSLS TTM CFI is now -100.00% below its all-time high of $8.82 million, reached on September 30, 2009.
Performance
RSLS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RSLS Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +89.1% | 0.0% | +100.0% |
3 y3 years | +99.6% | +100.0% | -100.0% |
5 y5 years | +99.9% | +100.0% | +100.0% |
RSLS Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -100.5% | +89.1% | -100.0% | +100.0% | -100.0% | +100.0% |
5 y | 5-year | -100.5% | +99.6% | -100.0% | +100.0% | -100.0% | +100.0% |
alltime | all time | -100.1% | +99.9% | -100.0% | +100.0% | -100.0% | +100.0% |
ReShape Lifesciences Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
Mar 2024 | - | $0.00(0.0%) | -$3000.00(-70.0%) |
Dec 2023 | -$10.00 K(-89.1%) | $0.00(0.0%) | -$10.00 K(-88.8%) |
Sep 2023 | - | $0.00(-100.0%) | -$89.00 K(-27.0%) |
Jun 2023 | - | -$3000.00(-57.1%) | -$122.00 K(+20.8%) |
Mar 2023 | - | -$7000.00(-91.1%) | -$101.00 K(+9.8%) |
Dec 2022 | -$92.00 K(-105.0%) | -$79.00 K(+139.4%) | -$92.00 K(-97.0%) |
Sep 2022 | - | -$33.00 K(-283.3%) | -$3.08 M(-1.8%) |
Jun 2022 | - | $18.00 K(+800.0%) | -$3.14 M(-258.7%) |
Mar 2022 | - | $2000.00(-100.1%) | $1.98 M(+6.5%) |
Dec 2021 | $1.85 M(-177.6%) | -$3.07 M(+3346.1%) | $1.85 M(-32.8%) |
Sep 2021 | - | -$89.00 K(-101.7%) | $2.76 M(+2.2%) |
Jun 2021 | - | $5.13 M(-4410.9%) | $2.70 M(-207.7%) |
Mar 2021 | - | -$119.00 K(-94.5%) | -$2.51 M(+5.0%) |
Dec 2020 | -$2.39 M(+18.7%) | -$2.16 M(+1359.5%) | -$2.39 M(+6.5%) |
Sep 2020 | - | -$148.00 K(+80.5%) | -$2.24 M(+7.1%) |
Jun 2020 | - | -$82.00 K(<-9900.0%) | -$2.10 M(+4.1%) |
Mar 2020 | - | $0.00(-100.0%) | -$2.01 M(0.0%) |
Dec 2019 | -$2.01 M(-80.5%) | -$2.01 M(<-9900.0%) | -$2.01 M(-80.5%) |
Sep 2019 | - | $0.00(0.0%) | -$10.32 M(0.0%) |
Jun 2019 | - | $0.00(-100.0%) | -$10.32 M(-0.1%) |
Dec 2018 | -$10.33 M(+62.2%) | -$10.32 M(<-9900.0%) | -$10.33 M(+133.8%) |
Sep 2018 | - | $0.00(-100.0%) | -$4.42 M(-2.3%) |
Jun 2018 | - | -$7000.00(<-9900.0%) | -$4.52 M(-29.0%) |
Mar 2018 | - | $0.00(-100.0%) | -$6.37 M(0.0%) |
Dec 2017 | -$6.37 M(>+9900.0%) | -$4.41 M(+4169.4%) | -$6.37 M(+224.9%) |
Sep 2017 | - | -$103.30 K(-94.4%) | -$1.96 M(+5.6%) |
Jun 2017 | - | -$1.85 M(<-9900.0%) | -$1.86 M(>+9900.0%) |
Mar 2017 | - | $0.00(-100.0%) | -$2500.00(-82.1%) |
Dec 2016 | -$14.00 K(-64.0%) | -$2500.00(<-9900.0%) | -$14.00 K(+6.1%) |
Sep 2016 | - | $0.00(0.0%) | -$13.20 K(-5.7%) |
Jun 2016 | - | $0.00(-100.0%) | -$14.00 K(-56.0%) |
Mar 2016 | - | -$11.50 K(+576.5%) | -$31.80 K(-18.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2015 | -$38.90 K(-56.1%) | -$1700.00(+112.5%) | -$39.00 K(-60.6%) |
Sep 2015 | - | -$800.00(-95.5%) | -$98.90 K(-14.7%) |
Jun 2015 | - | -$17.80 K(-4.8%) | -$115.90 K(+15.8%) |
Mar 2015 | - | -$18.70 K(-69.6%) | -$100.10 K(+12.9%) |
Dec 2014 | -$88.70 K(-58.9%) | -$61.60 K(+246.1%) | -$88.70 K(-153.0%) |
Sep 2014 | - | -$17.80 K(+790.0%) | $167.40 K(-181.9%) |
Jun 2014 | - | -$2000.00(-72.6%) | -$204.30 K(-7.0%) |
Mar 2014 | - | -$7300.00(-103.8%) | -$219.70 K(+1.7%) |
Dec 2013 | -$216.00 K(-123.4%) | $194.50 K(-149.9%) | -$216.00 K(-50.4%) |
Sep 2013 | - | -$389.50 K(+2138.5%) | -$435.10 K(-145.6%) |
Jun 2013 | - | -$17.40 K(+383.3%) | $954.40 K(-1.4%) |
Mar 2013 | - | -$3600.00(-85.4%) | $968.10 K(+4.8%) |
Dec 2012 | $923.60 K(-81.8%) | -$24.60 K(-102.5%) | $923.60 K(-68.5%) |
Sep 2012 | - | $1.00 M(<-9900.0%) | $2.94 M(-369.1%) |
Jun 2012 | - | -$3700.00(-92.3%) | -$1.09 M(-257.7%) |
Mar 2012 | - | -$48.10 K(-102.4%) | $691.70 K(-86.3%) |
Dec 2011 | $5.07 M(-177.6%) | $1.99 M(-165.7%) | $5.07 M(-247.0%) |
Sep 2011 | - | -$3.03 M(-270.1%) | -$3.45 M(+756.4%) |
Jun 2011 | - | $1.78 M(-58.9%) | -$402.50 K(-81.5%) |
Mar 2011 | - | $4.33 M(-166.3%) | -$2.18 M(-66.6%) |
Dec 2010 | -$6.53 M(-229.6%) | -$6.53 M(<-9900.0%) | -$6.53 M(>+9900.0%) |
Sep 2010 | - | $18.80 K(>+9900.0%) | -$22.60 K(-114.1%) |
Jun 2010 | - | $0.00(-100.0%) | $160.80 K(-78.4%) |
Mar 2010 | - | -$21.40 K(+7.0%) | $745.70 K(-85.2%) |
Dec 2009 | $5.04 M(+78.0%) | -$20.00 K(-109.9%) | $5.04 M(-42.9%) |
Sep 2009 | - | $202.20 K(-65.4%) | $8.82 M(+197.9%) |
Jun 2009 | - | $584.90 K(-86.3%) | $2.96 M(-43.9%) |
Mar 2009 | - | $4.27 M(+13.4%) | $5.28 M(+86.7%) |
Dec 2008 | $2.83 M(-65.7%) | $3.77 M(-166.5%) | $2.83 M(-402.7%) |
Sep 2008 | - | -$5.66 M(-294.7%) | -$935.20 K(-119.8%) |
Jun 2008 | - | $2.91 M(+59.8%) | $4.73 M(+159.8%) |
Mar 2008 | - | $1.82 M | $1.82 M |
Dec 2007 | $8.25 M(-146.7%) | - | - |
Dec 2006 | -$17.67 M(+3829.3%) | - | - |
Dec 2005 | -$449.80 K | - | - |
FAQ
- What is ReShape Lifesciences annual cash flow from investing activities?
- What is the all time high annual CFI for ReShape Lifesciences?
- What is ReShape Lifesciences annual CFI year-on-year change?
- What is ReShape Lifesciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly CFI year-on-year change?
- What is ReShape Lifesciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for ReShape Lifesciences?
- What is ReShape Lifesciences TTM CFI year-on-year change?
What is ReShape Lifesciences annual cash flow from investing activities?
The current annual CFI of RSLS is -$10.00 K
What is the all time high annual CFI for ReShape Lifesciences?
ReShape Lifesciences all-time high annual cash flow from investing activities is $8.25 M
What is ReShape Lifesciences annual CFI year-on-year change?
Over the past year, RSLS annual cash flow from investing activities has changed by +$82.00 K (+89.13%)
What is ReShape Lifesciences quarterly cash flow from investing activities?
The current quarterly CFI of RSLS is $0.00
What is the all time high quarterly CFI for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly cash flow from investing activities is $5.13 M
What is ReShape Lifesciences quarterly CFI year-on-year change?
Over the past year, RSLS quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is ReShape Lifesciences TTM cash flow from investing activities?
The current TTM CFI of RSLS is $0.00
What is the all time high TTM CFI for ReShape Lifesciences?
ReShape Lifesciences all-time high TTM cash flow from investing activities is $8.82 M
What is ReShape Lifesciences TTM CFI year-on-year change?
Over the past year, RSLS TTM cash flow from investing activities has changed by +$89.00 K (+100.00%)